Bioventus
Kelly Buddin is an experienced Senior Scientist in Research and Development, with previous roles as a Scientist and Associate Scientist at Bioventus. Prior to that, Kelly worked as a Senior Research Technician at Locus Biosciences, Inc., and as a Research Technician at Duke University. Kelly's research experience includes studying bacteriophage-mediated therapeutics, Calponin isoforms in cataracts, S100A4 and S100A5 roles in lens and retinal morphogenesis, and hypoxia inducible factors in oxidative injury response in the canine retina. Kelly holds a Bachelor's Degree in Genetics from North Carolina State University.
This person is not in any offices
Bioventus
4 followers
Bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus accomplishes this with its orthobiologic solutions for musculoskeletal healing and regeneration that engage and enhance the body’s healing process. The company has products for bone healing, bone graft and knee osteoarthritis. Established in 2012, Bioventus is privately held and headquartered in Durham, NC. The company has more than 700 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN and Toronto, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world, and generates $300 million dollars in yearly revenue.